Tarja Ruotsalainen
- Oncology top 10%
- Lung Cancer Research Studies 7
- Peptidase Inhibition and Analysis 3
-
- Cancer therapeutics and mechanisms 2
- Angiogenesis and VEGF in Cancer 2
-
- Oral health in cancer treatment 2
- Gastric Cancer Management and Outcomes 2
- Food Science top 10%
-
- Neuroendocrine Tumor Research Advances 2
-
- Genetic factors in colorectal cancer 2
- Co-authors
- Heikki JoensuuPetri SalvénKarin MattsonRiitta KorpelaPia ÖsterlundA OllusInkeri ElomaaMauri Kouri
- Partner nations
- FinlandItalyUnited States
In The Last Decade
Tarja Ruotsalainen
11 papers receiving 722 citations
Peers
Comparison fields: 5 of 74
- Oncology 352
- Molecular Biology 460
- Cancer Research 89
- Pulmonary and Respiratory Medicine 179
- Food Science 86
Countries citing papers authored by Tarja Ruotsalainen
This map shows the geographic impact of Tarja Ruotsalainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarja Ruotsalainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarja Ruotsalainen more than expected).
Fields of papers citing papers by Tarja Ruotsalainen
This network shows the impact of papers produced by Tarja Ruotsalainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarja Ruotsalainen. The network helps show where Tarja Ruotsalainen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tarja Ruotsalainen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 1 | |
| 2 | 2007 | 298 | |
| 3 | 2004 | 39 | |
| 4 | 2002 | 7 | |
| 5 | High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer. | 2002 | 65 |
| 6 | 2000 | 25 | |
| 7 | 1999 | 4 | |
| 8 | 1999 | 25 | |
| 9 | 1998 | 232 | |
| 10 | 1998 | 18 | |
| 11 | 1997 | 29 |
About Tarja Ruotsalainen
Tarja Ruotsalainen is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 743 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (7 papers), Peptidase Inhibition and Analysis (3 papers), Cancer therapeutics and mechanisms (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Oral health in cancer treatment (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Genetic factors in colorectal cancer (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Oncology (352 citations), Molecular Biology (460 citations) and Cancer Research (89 citations). Tarja Ruotsalainen has collaborated with scholars based in Finland, Italy and United States. Frequent co-authors include Heikki Joensuu, Petri Salvén, Karin Mattson, Riitta Korpela, Pia Österlund, A Ollus, Inkeri Elomaa, Mauri Kouri, M. Saxelin and Päivi Valta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.